Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Cord Blood Corporation Reports Second Quarter and First Half Fiscal 2011 Financial Results 2010-11-24 19:00
3SBio Inc. Announces Results of Annual General Meeting 2010-11-24 12:16
Weikang Bio-Technology Signs Three New Agent Contracts Which are Expected to Add $15 Million in Annual Sales 2010-11-22 20:00
3SBio Announces Conversion of Isotechnika Debenture 2010-11-19 01:30
China Cord Blood Corporation to Announce Second Quarter Fiscal 2011 Financial Results 2010-11-17 18:00
China Biologic Products Announces Record Third Quarter 2010 Results 2010-11-16 20:00
Weikang Bio-Technology Reports Record Third Quarter 2010 Financial Results; Revenue of $17 Million and Non-GAAP Net Income of $6.5 Million or $0.23 Earnings per Share 2010-11-15 20:00
Tianyin Reports Record First Quarter Fiscal Year 2011 Financial Results 2010-11-10 22:14
Huifeng Bio-Pharmaceutical Technology Enters into a US$3.9 Million Financing and Construction Agreement with Xi'an Jucheng Investment & Consulting Co., Ltd. 2010-11-10 20:30
Novasep and Mega Sign a Strategic Technology Partnership to Develop Whey Treatment Solutions for the Dairy Industry 2010-11-10 12:00
China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 2010-11-09 22:14
China Cord Blood Corporation Announces Proposed Public Offering of Ordinary Shares 2010-11-05 04:37
Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStem's Licensed Adult Stem Cell Treatments for Orthopedic Applications in China 2010-11-03 05:51
Sinovac to Host Conference Call to Report Third Quarter 2010 Unaudited Financial Results 2010-11-01 20:00
China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program 2010-10-22 16:00
China Cord Blood Corporation Files Its Annual Report on Form 20-F/A 2010-10-20 17:00
3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results 2010-10-18 17:14
TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic 2010-10-14 21:00
China-Biotics to Attend BNP Paribas China Conference 2010-10-12 00:34
Weikang Bio-Technology Reiterates Fiscal 2010 Revenue Guidance of $55 Million and Net Profit of $21 Million for $0.75 Earnings per Share 2010-10-11 19:00
1 443 444 445 446 447